IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,090,241 | +9.1% | 68,127 | -1.4% | 0.01% | 0.0% |
| Q2 2023 | $2,833,655 | -59.8% | 69,063 | -60.9% | 0.01% | -81.2% |
| Q2 2021 | $7,054,000 | +12.1% | 176,820 | +58.9% | 0.03% | -5.9% |
| Q4 2020 | $6,291,000 | +133.2% | 111,269 | +95.7% | 0.03% | +100.0% |
| Q3 2020 | $2,698,000 | +4323.0% | 56,862 | +5496.7% | 0.02% | – |
| Q4 2019 | $61,000 | +79.4% | 1,016 | +81.1% | 0.00% | – |
| Q3 2019 | $34,000 | +325.0% | 561 | +523.3% | 0.00% | – |
| Q1 2019 | $8,000 | -99.1% | 90 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $922,000 | -88.4% | 17,878 | -86.1% | 0.00% | -94.7% |
| Q4 2015 | $7,947,000 | – | 128,328 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |